The rodent protection test (RPT) is used in antimicrobial research to
confirm the in vivo efficacy of novel antibacterial, antiviral and ant
ifungal agents. The RPT may involve lethal infection and thus has the
potential to cause significant suffering. These Guidelines recommend r
efinements to the RPT which reduce animal use to a minimum and suggest
cardinal clinical signs which act as predictors of lethality. Early r
ecognition of these signs is imperative to minimize suffering, allow i
dentification of humane end points and permit timely euthanasia. Const
ructive suggestions for the improvement of these Guidelines are welcom
ed.